IPP Bureau

Symeres and Ambagon team up to target ‘undruggable’ proteins in colorectal cancer
Symeres and Ambagon team up to target ‘undruggable’ proteins in colorectal cancer

By IPP Bureau - April 07, 2026

Under the collaboration, Symeres will test Ambagon’s newly designed molecular glues using in vitro assays and mechanistic studies

World Health Day: Late diagnosis, rising lifestyle diseases put young India at risk
World Health Day: Late diagnosis, rising lifestyle diseases put young India at risk

By IPP Bureau - April 07, 2026

Sharp increase in diabetes, hypertension and fatty liver in 30–50 age group

Fischer Medical converts warrants into equity, infuses Rs 10.53 crore
Fischer Medical converts warrants into equity, infuses Rs 10.53 crore

By IPP Bureau - April 07, 2026

Board approves allotment of shares to promoter Shankar Varadharajan following warrant conversion under SEBI Regulation 30 disclosure

Aurobindo Pharma’s CuraTeQ achieves Phase 3 success for Omalizumab biosimilar
Aurobindo Pharma’s CuraTeQ achieves Phase 3 success for Omalizumab biosimilar

By IPP Bureau - April 07, 2026

The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline

HRV Pharma, Shodhana join hands to build next-gen API pipeline for global markets
HRV Pharma, Shodhana join hands to build next-gen API pipeline for global markets

By IPP Bureau - April 07, 2026

Multi-year CDMO partnership combines AI-led virtual development, precision chemistry and GMP manufacturing to accelerate five high-science APIs across regulated markets

MedGenome’s RNA-based NGS study sharpens sarcoma diagnosis, alters treatment in 25% cases
MedGenome’s RNA-based NGS study sharpens sarcoma diagnosis, alters treatment in 25% cases

By IPP Bureau - April 07, 2026

India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases

Lupin secures global Great Place To Work certification for 2026-27
Lupin secures global Great Place To Work certification for 2026-27

By IPP Bureau - April 07, 2026

Recognition across subsidiaries and geographies highlights pharma major’s focus on inclusive culture, employee experience, and global workforce development

Alembic Pharma wins USFDA nod for generic Dapagliflozin, secures 180-day exclusivity
Alembic Pharma wins USFDA nod for generic Dapagliflozin, secures 180-day exclusivity

By IPP Bureau - April 07, 2026

Final approval for diabetes and heart-failure drug opens access to a $10.5 billion US market opportunity, with shared exclusivity benefits.

Thyrocare’s Bharat Aarogyam score flags silent health risks in 9 out of 10 Indians
Thyrocare’s Bharat Aarogyam score flags silent health risks in 9 out of 10 Indians

By IPP Bureau - April 07, 2026

Analysis of over 93 lakh preventive health checkups reveals disease risks emerging as early as the 20s

SIMPACT 2026 convenes India’s healthcare leaders to advance simulation-driven education
SIMPACT 2026 convenes India’s healthcare leaders to advance simulation-driven education

By IPP Bureau - April 06, 2026

Participants also experienced a VR-enabled learning environment designed to support clinical skill development in controlled, repeatable, and risk-free settings

Dharmendra Singh Gangwar appointed CEO of Rajiv Gandhi Cancer Institute
Dharmendra Singh Gangwar appointed CEO of Rajiv Gandhi Cancer Institute

By IPP Bureau - April 06, 2026

Former Interim CEO takes charge to drive strategic growth, strengthen clinical excellence, and advance patient-centric oncology innovation

Syngene appoints Maninder Kapoor Puri as Chief Human Resources Officer
Syngene appoints Maninder Kapoor Puri as Chief Human Resources Officer

By IPP Bureau - April 06, 2026

Veteran HR leader comes with over two decades of experience to spearhead talent strategy, leadership development, and culture transformation

Sir Ganga Ram Hospital launches dialysis center in Gurgaon to expand renal care access
Sir Ganga Ram Hospital launches dialysis center in Gurgaon to expand renal care access

By IPP Bureau - April 06, 2026

New facility in Sector 51 offers advanced, affordable, and patient-centric dialysis services for NCR patients

Red Nucleus acquires Bridge Medical Consulting with advisory support from VERTICES PARTNERS
Red Nucleus acquires Bridge Medical Consulting with advisory support from VERTICES PARTNERS

By IPP Bureau - April 06, 2026

As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm

Samsung Biologics lands first US manufacturing facility with GSK acquisition
Samsung Biologics lands first US manufacturing facility with GSK acquisition

By IPP Bureau - April 06, 2026

Samsung Biologics will continue supplying products previously manufactured at the site to GSK

Latest Stories

Interviews

Packaging